Holen Sie sich die Stockscreener-App
49.75
0.48%
-0.24
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CYTK?
Forum
Prognose
Aktiensplit
Cytokinetics Inc Aktie (CYTK) Neueste Nachrichten
Is Cytokinetics Incorporated stock bottoming out2025 Market Sentiment & Fast Moving Trade Plans - Newser
Using Python tools to backtest Cytokinetics Incorporated strategiesJuly 2025 Sector Moves & Weekly Market Pulse Updates - Newser
Spinal Muscular Atrophy Market Positioned for Accelerated - openPR.com
How to read the order book for Cytokinetics Incorporated2025 Short Interest & Community Consensus Picks - Newser
How to manage a losing position in Cytokinetics IncorporatedJuly 2025 News Drivers & Proven Capital Preservation Tips - Newser
Movement Recap: Is Cytokinetics Incorporated a top pick in the sector2025 Trading Volume Trends & AI Based Trade Execution Alerts - khodrobank.com
Cytokinetics (CYTK) Rockets 40.45% as Aficamten Results Promising - MSN
Cytokinetics Incorporated stock prediction for this week2025 Risk Factors & Long-Term Growth Portfolio Plans - Newser
Cytokinetics Gains on Positive Late-Stage Cardiomyopathy Study Results - Zacks Investment Research
Cytokinetics shares fall 1.15% premarket after insider sold shares worth $337,800. - AInvest
Will Cytokinetics Incorporated benefit from rate cutsInsider Selling & Risk Controlled Stock Alerts - khodrobank.com
Understanding Cytokinetics Incorporated’s price movement2025 Biggest Moves & Community Trade Idea Sharing Platform - Newser
Does Cytokinetics Incorporated show high probability of reboundJuly 2025 PostEarnings & Long Hold Capital Preservation Tips - Newser
Predicting Cytokinetics Incorporated trend using moving averagesGDP Growth & Safe Entry Trade Reports - Newser
Can Cytokinetics Incorporated recover in the next quarterMarket Rally & Free Safe Capital Growth Stock Tips - Newser
Is Cytokinetics Incorporated’s ROE strong enoughMarket Sentiment Review & AI Driven Stock Price Forecasts - khodrobank.com
Applying chart zones and confluence areas to Cytokinetics Incorporated2025 Year in Review & Growth Oriented Trade Recommendations - Newser
What’s next for Cytokinetics Incorporated stock pricePortfolio Profit Report & Long-Term Growth Plans - Newser
Technical signs of recovery in Cytokinetics IncorporatedMarket Sentiment Summary & Safe Entry Zone Tips - Newser
Detecting support and resistance levels for Cytokinetics IncorporatedChart Signals & High Win Rate Trade Alerts - Newser
How high can Cytokinetics Incorporated stock goJuly 2025 Macro Moves & Long-Term Growth Stock Strategies - Newser
Real time social sentiment graph for Cytokinetics IncorporatedTrade Risk Report & Low Drawdown Trading Techniques - Newser
Cytokinetics’ Aficamten with breakthrough Phase III results - European Biotechnology Magazine
Cytokinetics Shares Jump 40.45% on Aficamten HCM Data $630M Volume Ranks 162nd - AInvest
Is Cytokinetics Incorporated on track to beat earnings2025 Key Highlights & Smart Swing Trading Techniques - khodrobank.com
Should I buy Cytokinetics Incorporated stock nowIPO Watch & Daily Profit Maximizing Trade Tips - khodrobank.com
Cytokinetics’ Aficamten Shows Head-To-Head Advantage Vs. Beta Blockers - insights.citeline.com
Growth or Bubble? Decoding Cytokinetics’ Surge - timothysykes.com
Nvidia, PepsiCo, Tesla, Kraft Heinz, Constellation Brands, Cytokinetics, and More Market Movers - Barron's
Cytokinetics at Citi’s Biopharma Conference: Aficamten’s Promising Path - Investing.com
Cytokinetics Skyrockets On 'Provocative' Results In Heart Disease - Investor's Business Daily
Aficamten Bests Metoprolol in Cytokinetics' Trial for Obstructive Hypertrophic Cardiomyopathy - PharmTech
Bitcoin gains, Frontier upgraded, Cytokinetics trial results - Yahoo Finance
Cytokinetics: Game-Changing Data Confirms Best-In-Class Potential (NASDAQ:CYTK) - Seeking Alpha
Stifel raises Cytokinetics stock price target to $96 on bullish outlook - Investing.com
Cytokinetics says heart disease drug more effective than standard-of-care, shares jump - TradingView
Cytokinetics’ Aficamten: Navigating Regulatory Hurdles and Market Potential in the OHCM Space - AInvest
Cytokinetics Appoints New Director Amid Revenue Boost and Strategic Moves - StocksToTrade
Board Appointment Boosts Cytokinetics’ Growth Projections - timothysykes.com
Cytokinetics Shares are Jumping. Its Heart Drug Looks Better than Ever - Barron's
Cytokinetics (CYTK) Stock Is Skyrocketing Tuesday: What's Driving The Action? - Benzinga
Will Cytokinetics Incorporated face regulatory challengesWeekly Investment Summary & Precise Buy Zone Identification - khodrobank.com
Cytokinetics stock soars after impressive heart drug data By Investing.com - Investing.com Canada
Cytokinetics makes its case for heart-failure drug ahead of FDA decision, stock surges more than 40% - The Business Journals
Cytokinetics shares surge 35.66% in premarket after positive results from MAPLE-HCM III trial. - AInvest
Cytokinetics Soars 35.13% on Promising Heart Disease Data - AInvest
Fed Watch: Is Cytokinetics Incorporated a top pick in the sectorCEO Change & Safe Investment Capital Preservation Plans - خودرو بانک
Retail Buzz Soars As Cytokinetics Jumps 34% In Europe On Heart Drug Breakthrough - Stocktwits
Is Cytokinetics Incorporated forming a reversal patternJuly 2025 Review & Safe Capital Investment Plans - Newser
Pattern recognition hints at Cytokinetics Incorporated upside2025 Top Gainers & Free Weekly Watchlist of Top Performers - Newser
Multi asset correlation models including Cytokinetics IncorporatedQuarterly Trade Summary & Step-by-Step Trade Execution Guides - Newser
Risk adjusted return profile for Cytokinetics Incorporated analyzedMarket Growth Summary & Technical Pattern Based Signals - Newser
Published on: 2025-09-01 20:47:13 - khodrobank.com
Cytokinetics Incorporated stock retracement – recovery analysis2025 Investor Takeaways & Daily Stock Trend Watchlist - Newser
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):